tm
Seeing Is Believing
tm
Seeing Is Believing
with an average price target of $-35.51. This is a potential upside of $-50.61 (-335.17%) from yesterday's end of day stock price of $15.1.
Neoleukin Therapeutics's activity chart (see below) currently has 29 price targets and 28 ratings on display.
Analysts average stock forecasts to be materialized ratio is 90.28% with an average time for these price targets to be met of 454.75 days.
Most recent stock forecast was given by MARA GOLDSTEIN from MIZUHO on 08-May-2023. First documented stock forecast 16-Mar-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$7.5
$-7.6 (-50.33%)
$10
2 years 5 months 20 days ago
(08-May-2023)
3/3 (100%)
$-10.3 (-57.87%)
252
Hold
$30
2 years 11 months 13 days ago
(15-Nov-2022)
1/2 (50%)
$8.6 (40.19%)
584
Hold
$4.5
$-10.6 (-70.20%)
$90
2 years 11 months 14 days ago
(14-Nov-2022)
2/2 (100%)
$-4 (-47.06%)
379
Hold
$100
2 years 11 months 14 days ago
(14-Nov-2022)
1/1 (100%)
$-122.2 (-55.00%)
643
Buy
$15
$-0.1 (-0.66%)
$90
3 years 1 months 17 days ago
(11-Sep-2022)
2/2 (100%)
$-6.4 (-29.91%)
335
What is NLTX (Neoleukin Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on NLTX (Neoleukin Therapeutics) with a proven track record?
Which analyst has the most public recommendations on NLTX (Neoleukin Therapeutics)?
Which analyst is the currently most bullish on NLTX (Neoleukin Therapeutics)?
Which analyst is the currently most reserved on NLTX (Neoleukin Therapeutics)?
